Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China
· Delayed Price · Currency is CNY 10.71
+0.20 (1.90%)
Mar 10, 2026, 12:24 PM CST
SHE:301060 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,188 | 3,634 | 5,323 | 7,854 | 13,910 | - | Upgrade
|
| Market Cap Growth | -1.50% | -31.73% | -32.23% | -43.54% | - | - | Upgrade
|
| Enterprise Value | 3,741 | 3,446 | 5,270 | 7,890 | 13,408 | - | Upgrade
|
| Last Close Price | 10.51 | 8.92 | 13.01 | 18.85 | 33.13 | - | Upgrade
|
| PE Ratio | - | - | - | 12.72 | 68.24 | - | Upgrade
|
| PS Ratio | 2.75 | 2.09 | 3.18 | 1.87 | 7.82 | - | Upgrade
|
| PB Ratio | 2.51 | 2.00 | 2.69 | 3.46 | 8.48 | - | Upgrade
|
| P/TBV Ratio | 2.70 | 2.24 | 3.06 | 3.86 | 9.15 | - | Upgrade
|
| P/FCF Ratio | 11.79 | 26.01 | 35.94 | - | 132.95 | - | Upgrade
|
| P/OCF Ratio | 10.06 | 16.80 | 9.73 | 93.32 | 62.23 | - | Upgrade
|
| EV/Sales Ratio | 2.45 | 1.98 | 3.15 | 1.88 | 7.54 | - | Upgrade
|
| EV/EBITDA Ratio | 99.82 | - | - | 6.96 | 39.56 | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | 7.37 | 45.58 | - | Upgrade
|
| EV/FCF Ratio | 10.53 | 24.67 | 35.58 | - | 128.15 | - | Upgrade
|
| Debt / Equity Ratio | 0.12 | 0.15 | 0.21 | 0.11 | 0.04 | - | Upgrade
|
| Debt / EBITDA Ratio | 5.47 | 25.15 | - | 0.21 | 0.19 | - | Upgrade
|
| Debt / FCF Ratio | 0.58 | 1.96 | 2.75 | - | 0.63 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.32 | -0.30 | -0.23 | -0.18 | -0.43 | -0.43 | Upgrade
|
| Net Debt / EBITDA Ratio | -22.66 | 202.84 | 4.27 | -0.37 | -2.09 | -2.64 | Upgrade
|
| Net Debt / FCF Ratio | -1.52 | -3.97 | -3.06 | 2.89 | -6.76 | -4.32 | Upgrade
|
| Asset Turnover | 0.60 | 0.62 | 0.50 | 1.44 | 0.99 | 0.86 | Upgrade
|
| Inventory Turnover | 3.85 | 4.18 | 3.50 | 8.95 | 7.72 | 5.26 | Upgrade
|
| Quick Ratio | 2.48 | 2.68 | 2.31 | 2.07 | 3.88 | 4.96 | Upgrade
|
| Current Ratio | 3.08 | 3.25 | 2.83 | 2.40 | 4.28 | 5.75 | Upgrade
|
| Return on Equity (ROE) | -1.97% | -5.19% | -7.61% | 37.78% | 18.12% | 10.93% | Upgrade
|
| Return on Assets (ROA) | -1.07% | -1.39% | -2.89% | 22.88% | 10.28% | 6.89% | Upgrade
|
| Return on Invested Capital (ROIC) | -3.79% | -4.47% | -9.21% | 62.87% | 28.25% | 18.17% | Upgrade
|
| Return on Capital Employed (ROCE) | -2.40% | -3.10% | -7.20% | 45.90% | 17.40% | 12.60% | Upgrade
|
| Earnings Yield | -1.66% | -3.01% | -2.66% | 7.86% | 1.47% | - | Upgrade
|
| FCF Yield | 8.48% | 3.84% | 2.78% | -1.86% | 0.75% | - | Upgrade
|
| Dividend Yield | 1.89% | 2.24% | - | 1.59% | 0.91% | - | Upgrade
|
| Payout Ratio | - | - | - | 20.35% | 0.15% | 31.95% | Upgrade
|
| Buyback Yield / Dilution | -0.51% | -0.19% | -1.00% | -13.63% | -0.02% | 0.02% | Upgrade
|
| Total Shareholder Return | 1.38% | 2.05% | -1.00% | -12.04% | 0.89% | 0.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.